Correlation Between PhaseBio Pharmaceuticals and Mosaic Immunoengineerin

Can any of the company-specific risk be diversified away by investing in both PhaseBio Pharmaceuticals and Mosaic Immunoengineerin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PhaseBio Pharmaceuticals and Mosaic Immunoengineerin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PhaseBio Pharmaceuticals and Mosaic Immunoengineering, you can compare the effects of market volatilities on PhaseBio Pharmaceuticals and Mosaic Immunoengineerin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PhaseBio Pharmaceuticals with a short position of Mosaic Immunoengineerin. Check out your portfolio center. Please also check ongoing floating volatility patterns of PhaseBio Pharmaceuticals and Mosaic Immunoengineerin.

Diversification Opportunities for PhaseBio Pharmaceuticals and Mosaic Immunoengineerin

0.0

Correlation Coefficient

PhaseBio Pharmaceuticals  Mosaic Immunoengineerin

Pay attention - limited upside

The 3 months correlation between PhaseBio and Mosaic is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding PhaseBio Pharmaceuticals and Mosaic Immunoengineering in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mosaic Immunoengineering and PhaseBio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PhaseBio Pharmaceuticals are associated (or correlated) with Mosaic Immunoengineerin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mosaic Immunoengineering has no effect on the direction of PhaseBio Pharmaceuticals i.e., PhaseBio Pharmaceuticals and Mosaic Immunoengineerin go up and down completely randomly.

Pair Corralation between PhaseBio Pharmaceuticals and Mosaic Immunoengineerin

If you would invest  100.00  in Mosaic Immunoengineering on December 2, 2024 and sell it today you would lose (2.00) from holding Mosaic Immunoengineering or give up 2.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

PhaseBio Pharmaceuticals  vs.  Mosaic Immunoengineering

PhaseBio Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days PhaseBio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, PhaseBio Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Mosaic Immunoengineering

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mosaic Immunoengineering are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Mosaic Immunoengineerin showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with PhaseBio Pharmaceuticals and Mosaic Immunoengineerin

The main advantage of trading using opposite PhaseBio Pharmaceuticals and Mosaic Immunoengineerin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PhaseBio Pharmaceuticals position performs unexpectedly, Mosaic Immunoengineerin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mosaic Immunoengineerin will offset losses from the drop in Mosaic Immunoengineerin's long position.

The idea behind PhaseBio Pharmaceuticals and Mosaic Immunoengineering pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.